Zoekresultaten - Eric J. Small

Verfijn jouw resultaten
  1. 1
    Simultaneous antiandrogen withdrawal and treatment with ketoconazole and hydrocortisone in patients with advanced prostate carcinoma

    Simultaneous antiandrogen withdrawal and treatment with ketoconazole and hydrocortisone in patients with advanced prostate carcinoma door Eric J. Small, Ari David Baron, Robert Bok

    Gepubliceerd in 1997
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  2. 2
    Malignant rhabdoid tumor of the heart in an infant

    Malignant rhabdoid tumor of the heart in an infant door Eric J. Small, Beverly Barrett Dahms, Gregory J. Gordon

    Gepubliceerd in 1985
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  3. 3
    A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102

    A phase II trial of cisplatin (C), gemcitabine (G) and gefitinib for advanced urothelial tract carcinoma: results of Cancer and Leukemia Group B (CALGB) 90102 door George Philips, Susan Halabi, Ben L. Sanford, Dean F. Bajorin, Eric J. Small

    Gepubliceerd in 2009
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  4. 4
    Cancer and Leukemia Group B 90206

    Cancer and Leukemia Group B 90206 door Brian I. Rini, Susan Halabi, John Taylor, Eric J. Small, Richard L. Schilsky

    Gepubliceerd in 2004
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  5. 5
    Germline and Somatic Mutations in Prostate Cancer for the Clinician

    Germline and Somatic Mutations in Prostate Cancer for the Clinician door Heather H. Cheng, Alexandra Sokolova, Edward M. Schaeffer, Eric J. Small, Celestia S. Higano

    Gepubliceerd in 2019
    Volledige tekst
    Revisão
    Toevoegen aan favorieten
    Bewaard in:
  6. 6
    Combination immunotherapy with prostatic acid phosphatase pulsed antigen‐presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer after definitive local therapy

    Combination immunotherapy with prostatic acid phosphatase pulsed antigen‐presenting cells (provenge) plus bevacizumab in patients with serologic progression of prostate cancer afte... door Brian I. Rini, Vivian Weinberg, Lawrence Fong, Shauna Conry, Robert M. Hershberg, Eric J. Small

    Gepubliceerd in 2006
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  7. 7
    Progression-Free Survival as a Predictor of Overall Survival in Men With Castrate-Resistant Prostate Cancer

    Progression-Free Survival as a Predictor of Overall Survival in Men With Castrate-Resistant Prostate Cancer door Susan Halabi, Nicholas J. Vogelzang, San‐San Ou, Kouros Owzar, Laura Archer, Eric J. Small

    Gepubliceerd in 2009
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  8. 8
    Adrenal Androgen Levels as Predictors of Outcome in Prostate Cancer Patients Treated with Ketoconazole Plus Antiandrogen Withdrawal: Results from a Cancer and Leukemia Group B Study

    Adrenal Androgen Levels as Predictors of Outcome in Prostate Cancer Patients Treated with Ketoconazole Plus Antiandrogen Withdrawal: Results from a Cancer and Leukemia Group B Stud... door Charles J. Ryan, Susan Halabi, San-San Ou, Nicholas J. Vogelzang, Philip W. Kantoff, Eric J. Small

    Gepubliceerd in 2007
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  9. 9
    A Phase II study of estramustine, docetaxel, and carboplatin with granulocyte–colony‐stimulating factor support in patients with hormone‐refractory prostate carcinoma

    A Phase II study of estramustine, docetaxel, and carboplatin with granulocyte–colony‐stimulating factor support in patients with hormone‐refractory prostate carcinoma door William Oh, Susan Halabi, William Kevin Kelly, Cary Werner, Paul A. Godley, Nicholas J. Vogelzang, Eric J. Small

    Gepubliceerd in 2003
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  10. 10
    Diversity of Antigen-Specific Responses Induced In Vivo with CTLA-4 Blockade in Prostate Cancer Patients

    Diversity of Antigen-Specific Responses Induced In Vivo with CTLA-4 Blockade in Prostate Cancer Patients door Serena S. Kwek, Vinh Dao, Ritu Roy, Yafei Hou, David Alajajian, Jeffrey P. Simko, Eric J. Small, Lawrence Fong

    Gepubliceerd in 2012
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  11. 11
    A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma

    A randomized study comparing standard versus moderately high dose megestrol acetate for patients with advanced prostate carcinoma door Nancy A. Dawson, Mark Conaway, Susan Halabi, Eric P. Winer, Eric J. Small, Diana Lake, Nicholas J. Vogelzang

    Gepubliceerd in 2000
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  12. 12
    The Prognostic Significance of Plasma Interleukin-6 Levels in Patients with Metastatic Hormone-Refractory Prostate Cancer: Results from Cancer and Leukemia Group B 9480

    The Prognostic Significance of Plasma Interleukin-6 Levels in Patients with Metastatic Hormone-Refractory Prostate Cancer: Results from Cancer and Leukemia Group B 9480 door Daniel J. George, Susan Halabi, Timothy F. Shepard, Ben L. Sanford, Nicholas J. Vogelzang, Eric J. Small, Philip W. Kantoff

    Gepubliceerd in 2005
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  13. 13
    Prostate-Specific Antigen Changes As Surrogate for Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Second-Line Chemotherapy

    Prostate-Specific Antigen Changes As Surrogate for Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Second-Line Chemotherapy door Susan Halabi, Andrew J. Armstrong, Oliver Sartor, Johann S. de Bono, Ellen B. Kaplan, Chen‐Yen Lin, Nicole Solomon, Eric J. Small

    Gepubliceerd in 2013
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  14. 14
    A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate‐resistant prostate cancer

    A phase 2 study of estramustine, docetaxel, and bevacizumab in men with castrate‐resistant prostate cancer door Joel Picus, Susan Halabi, William Kevin Kelly, Nicholas J. Vogelzang, Young E. Whang, Ellen B. Kaplan, Walter M. Stadler, Eric J. Small

    Gepubliceerd in 2010
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  15. 15
    A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma

    A phase 1 study of everolimus and sorafenib for metastatic clear cell renal cell carcinoma door Andrea Harzstark, Eric J. Small, Vivian Weinberg, Janine Sun, Charles J. Ryan, Amy Lin, Lawrence Fong, Dion R. Brocks, Jonathan E. Rosenberg

    Gepubliceerd in 2011
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  16. 16
    Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer

    Updated Prognostic Model for Predicting Overall Survival in First-Line Chemotherapy for Patients With Metastatic Castration-Resistant Prostate Cancer door Susan Halabi, Chen‐Yen Lin, William K. Kelly, Karim Fizazi, Judd W. Moul, Ellen B. Kaplan, Michael J. Morris, Eric J. Small

    Gepubliceerd in 2014
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  17. 17
    Prospective Trial of the Herbal Supplement PC-SPES in Patients With Progressive Prostate Cancer

    Prospective Trial of the Herbal Supplement PC-SPES in Patients With Progressive Prostate Cancer door Eric J. Small, Mark W. Frohlich, Robert Bok, Katsuto Shinohara, Gary D. Grossfeld, Zinovi Rozenblat, Wm. Kevin Kelly, Michele Corry, David Reese

    Gepubliceerd in 2000
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  18. 18
    CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion

    CTLA4 blockade expands FoxP3+ regulatory and activated effector CD4+ T cells in a dose-dependent fashion door Brian D. Kavanagh, Shaun O’Brien, David S. Lee, Yafei Hou, Vivian Weinberg, Brian I. Rini, James P. Allison, Eric J. Small, Lawrence Fong

    Gepubliceerd in 2008
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  19. 19
    Activity of second‐line chemotherapy in docetaxel‐refractory hormone‐refractory prostate cancer patients

    Activity of second‐line chemotherapy in docetaxel‐refractory hormone‐refractory prostate cancer patients door Jonathan E. Rosenberg, Vivian Weinberg, William K. Kelly, M. Dror Michaelson, Maha Hussain, George Wilding, Mitchell E. Gross, Douglass Hutcheon, Eric J. Small

    Gepubliceerd in 2007
    Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:
  20. 20
    Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in Prostate Cancer Patients Treated with Ipilimumab

    Preexisting Levels of CD4 T Cells Expressing PD-1 Are Related to Overall Survival in Prostate Cancer Patients Treated with Ipilimumab door Serena S. Kwek, Jera Lewis, Li Zhang, Vivian Weinberg, Samantha K. Greaney, Andrea Harzstark, Amy Lin, Charles J. Ryan, Eric J. Small, Lawrence Fong

    Gepubliceerd in 2015
    Volledige tekst Volledige tekst
    Artigo
    Toevoegen aan favorieten
    Bewaard in:

Zoekinstrumenten: